PTEN公司
张力素
PI3K/AKT/mTOR通路
蛋白激酶B
碱性磷酸酶
化学
磷酸酶
免疫印迹
细胞分化
细胞生物学
信号转导
分子生物学
磷酸化
生物
生物化学
基因
酶
作者
Yao Zhu,Cheng‐Yu Lin,Xudong Zhang,Zuyun Qiu,Lei Shi,Jianmin Li
标识
DOI:10.2174/0115665240333454241203050356
摘要
BACKGROUND: This study focuses on exploring the impact of Astragaloside IV [AS-IV] on osteogenic differentiation. METHODS: Osteogenic differentiation was induced in rat osteoblasts, following which treatment with AS-IV at varied doses was performed. Using Alizarin red staining and alkaline phosphatase (ALP) detection assay, the osteogenic differentiation of the cells was investigated. The expressions of osteogenic differentiation-related genes were determined by quantitative real-time polymerase chain reaction (qRT-PCR). The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathwayassociated protein expressions were examined using Western blot. After osteoblasts were transfected with protein tyrosine phosphatase non-receptor type 2 (PTPN2) overexpression plasmid, the impact of PTPN2 on osteoblasts treated with AS-IV was examined. RESULTS: AS-IV treatment enhanced osteogenic differentiation and up-regulated the expression of osteogenic differentiation-related genes, as well as the levels of p- PI3K/PI3K and p-AKT/AKT, while reducing phosphatase and tensin homolog (PTEN) protein production in osteoblasts. Overexpression of PTEN inhibited osteogenic differentiation, and PTPN2 overexpression counteracted the effects of AS-IV on osteogenic differentiation. CONCLUSION: AS-IV contributing to osteogenic differentiation may be related to the PTPN2-mediated PTEN/PI3K/Akt pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI